| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/29/2004 | CN1533387A 1-phenysulfonyl-1,3-dihydro-2H-indole-2-one derivatives, their preparation and their therapeutic use |
| 09/29/2004 | CN1533382A 哌嗪衍生物 Piperazine derivatives |
| 09/29/2004 | CN1533374A Substitutled cyclohexane-1,4-diamine derivatives |
| 09/29/2004 | CN1533293A Combinations comprising epothilones and pharmaceutical uses thereof |
| 09/29/2004 | CN1533280A Carbohydrate modifying agent and drinks containing the same |
| 09/29/2004 | CN1533277A Preventives or remedies for diseases caused by e NOS expression |
| 09/29/2004 | CN1533276A Use of thiazole derivatives for preparing medicine for protecting mitochondria |
| 09/29/2004 | CN1533275A Use of 4-[(4-thiazolyl) phenoxl] alkoxy-benzamidine derivatives for treatment of osteoporosis |
| 09/29/2004 | CN1533270A Oral administered dosage form of GABA anolog prodrugs having reduced toxicity |
| 09/29/2004 | CN1533242A Foot and mouth disease virus vaccine |
| 09/29/2004 | CN1531971A Treating acute damage caused local tissue necrosis by combined monoclonal antibody |
| 09/29/2004 | CN1531924A Use of isovaleric acid derivatives CNS inhibitors in preparing medicine for curing headache |
| 09/29/2004 | CN1168738C Biotin derivatives |
| 09/29/2004 | CN1168733C Novel prodrugs for therapy of tumors and inflammatory disorders |
| 09/29/2004 | CN1168728C Pyrrolo-isoquinoline and tetrahydropyrrolko-isoquinoline derivatives and their use as mediators of 5-HT7 reactor |
| 09/29/2004 | CN1168727C Substituted benzimidazole |
| 09/29/2004 | CN1168721C 5-cyano-2-aminopyrimidine derivatives |
| 09/29/2004 | CN1168720C Aryl alkanoylpyridazines compounds |
| 09/29/2004 | CN1168719C 6-phenylpyridyl-2-amine derivatives and pharmaceutical composition and use |
| 09/29/2004 | CN1168717C Novel intermediates for prepn. of antihisatminic piperidine derivatives |
| 09/29/2004 | CN1168712C Crystaline forms of sodium salt of 5-chloro-2-methoxy-N-(2(4- methoxy-3-methylaminothio carbonylamino sulfonylphenyl)ethyl) benzamide |
| 09/29/2004 | CN1168709C Alpha-hydroxy, amino and fluoro derivatives of beta-sulphenyl hdyroxamic acids matrix metalloproteinase inhibitors |
| 09/29/2004 | CN1168502C Porcine circovirus and parvovirus vaccine |
| 09/29/2004 | CN1168499C Medicament for optimising mucosal viscosity and stimulating intestinal function |
| 09/29/2004 | CN1168492C Use of activated protein C in porducing medicine and unit formulation containing activated protein C |
| 09/29/2004 | CN1168490C Health-care products extracted from ostrich blood, penis orchis |
| 09/29/2004 | CN1168474C Foot health keeping medicine |
| 09/29/2004 | CN1168451C Use of thiazolidinedione and sulphonylurea composition in preparing medicine for treating diabetes |
| 09/29/2004 | CN1168448C Medicament for preventing and/or treating a memmary carcinoma, containing a steroidal aromatase inhibitor |
| 09/29/2004 | CN1168445C Concentrated clear solution contg. biocefalin as brain metabolism improving medicine for intravenous injection after diluting it |
| 09/29/2004 | CN1168441C Use of dexmedetomidine for ICU sedation |
| 09/28/2004 | US6797726 N-alkoxyalkyl-N,N-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same |
| 09/28/2004 | US6797722 Use of 3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole for the treatment of autoimmune diseases |
| 09/28/2004 | US6797718 Ether substituted imidazopyridines |
| 09/28/2004 | US6797716 Imidazonaphthyridines |
| 09/28/2004 | US6797713 1,4 substituted piperazines, 1,4 substituted piperidines, and 1-substituted,4-alkylidenyl piperidine compounds; dual acting molecules having both leukotriene inhibition properties |
| 09/28/2004 | US6797706 Heterocyclecarboxamide derivative |
| 09/28/2004 | US6797699 Exemplified by n'-l-arginylspermidine |
| 09/28/2004 | US6797692 Use of glutamate antagonists for the treatment of cancer |
| 09/28/2004 | US6797511 Basis of its ability to bind to presenilin 1; for treatment of alzheimer's disease |
| 09/28/2004 | US6797504 For prevention and treatment of cancer, tumors, metastasis; drug screening |
| 09/28/2004 | US6797499 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof |
| 09/28/2004 | US6797489 PP14 fusion proteins and methods for making and using the same |
| 09/28/2004 | US6797291 Comprises protective lipid coating (hydrogenated oils) for choline chloride or lysine hydrochloride; ruminant feeds |
| 09/28/2004 | US6797265 Therapy for metabolism disorders; gene therapy |
| 09/28/2004 | US6797259 Delivery of muscle relaxants through an inhalation route |
| 09/28/2004 | CA2299013C Neuropeptide y antagonists |
| 09/28/2004 | CA2224125C Pharmaceutical composition comprising a proteinase inhibitor and a monoglyceride |
| 09/28/2004 | CA2191088C Copolymer-1 improvements in compositions of copolymers |
| 09/23/2004 | WO2004081050A1 Antibody against tumor specific antigen as target |
| 09/23/2004 | WO2004081013A1 Protein kinase inhibitors |
| 09/23/2004 | WO2004081001A1 Novel 2-pyridinecarboxamide derivatives |
| 09/23/2004 | WO2004080966A1 Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient |
| 09/23/2004 | WO2004080965A1 Neuropeptide ff receptor antagonist |
| 09/23/2004 | WO2004080487A1 Preventive or remedy for teeth grinding |
| 09/23/2004 | WO2004080485A1 Preventive/remedy for diseases in upper digestive tract |
| 09/23/2004 | WO2004080484A1 Adipocyte differentiation inhibitor |
| 09/23/2004 | WO2004080462A1 c-Kit KINASE INHIBITOR |
| 09/23/2004 | WO2004080452A1 Remedies for retinal diseases |
| 09/23/2004 | WO2004080439A1 Drug composition having active ingredient adhered at high concentration to spherical core |
| 09/23/2004 | WO2004080209A1 Serum remnant-like lipoprotein concentration regulator |
| 09/23/2004 | WO2004058353A3 Therapeutic use of selective noradrenaline reuptake inhibitors |
| 09/23/2004 | WO2004052365A3 Inhibition of inflamation using alpha 7 receptor-binding cholinergic agonists |
| 09/23/2004 | WO2004049964A3 Drug to be introduced tooth or periodontal tissue and apparatus for introducing drug to tooth or periodontal tissue |
| 09/23/2004 | WO2003106621A3 Anti-igf-i receptor antibody |
| 09/23/2004 | WO2003094836A3 Methods and products for enhancing immune responses using imidazoquinoline compounds |
| 09/23/2004 | WO2003086175A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 09/23/2004 | WO2003072017A3 Macromolecular conjugates and processes for preparing same |
| 09/23/2004 | WO2003064449A3 Bioactive keratin peptides |
| 09/23/2004 | WO2003063782A3 Kappa-pviia-related conotoxins as organ protectants |
| 09/23/2004 | WO2003005956A3 A hydroxamic acid thrombospondin peptide analog that inhibits aggrecanase activity |
| 09/23/2004 | US20040186299 such as 3-(3,5-dimethoxyphenyl)-2-{4-[4-(2,4-dioxothiazolidin-5-ylmethyl)-phenoxy]-phenyl}-acrylic acid; for lowering blood glucose level, serum insulin, triglyceride and free fatty acid levels in animal models of Type II diabetes; for increasing leptin levels with no liver toxicity |
| 09/23/2004 | US20040186288 3,5-Diamino-1,2,4-triazoles as kinase inhibitors |
| 09/23/2004 | US20040186275 Sarcomere binding polypeptide for use in diagnosis and treatment of diabetes and cardiomyopathies; diuretics; vasodilation; antiarrhythmic agents |
| 09/23/2004 | US20040186273 Prion-binding ligands and methods of using same |
| 09/23/2004 | US20040186179 Pharmaceutical composition |
| 09/23/2004 | US20040186178 Amidino compounds useful as nitric oxide synthase inhibitors |
| 09/23/2004 | US20040186163 Novel combination |
| 09/23/2004 | US20040186159 used to treat glaucomatous optic neuropathy and/or lower and control intraocular pressure (IOP) associated with normal-tension glaucoma, ocular hypertension, and/or glaucoma in warm blooded animals, including man |
| 09/23/2004 | US20040186157 inhibiting kinases; for treating or preventing neoplasia, rheumatoid arthritis, pulmonary fibrosis, myelofibrosis, abnormal wound healing, atherosclerosis, or restenosis, alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, stroke, ischaemia, Huntington's disease, AIDS dementia |
| 09/23/2004 | US20040186150 4-{5-[4-(5-Isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy]pentoxy}-benzamidine or N-hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy]pentoxy}-benzamidine (DW-1350); a leukotriene-B4 receptor antangonist; inhibiting osteoclastic bone absorption |
| 09/23/2004 | US20040186145 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 09/23/2004 | US20040186144 Use of vitamin B6 to mitigate visual field defects associated with the use of GABAergic drugs in mammals |
| 09/23/2004 | US20040186134 Inhibitors of Factor Xa are useful as anticoagulants in the treatment of cardiovascular disorders associated with thromboses; e.g., 1,1-dimethylethyl 1-[1-(-2-(-3-[2-(5-Chloro-thiophen-2-yl)-ethenesulfonylamino]-2-oxo-piperidin-1-yl)-acetyl)-pyrrolidin-2- yl-methyl]-pyrrolidin-3-yl}-methyl-carbamate |
| 09/23/2004 | US20040186133 preferably antagonists used in the therapeutic and/or preventive treatment of disfunctions of the heart, kidney, respiratory system, central nervous system |
| 09/23/2004 | US20040186130 Delivery of muscle relaxants through an inhalation route |
| 09/23/2004 | US20040186127 E.g., 7-(5-(2-(cyclohexylmethylamino)ethyl)indol-2-yl), 2-methyl-3H-imidazo(4,5-b)pyridine; antiinflammatory agents; antiproliferative agents; autoimmune diseases; reperfusion injuries; osteoporosis; bone disorders; antimetastasis agents |
| 09/23/2004 | US20040186126 Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 09/23/2004 | US20040186121 Tamper-resistant oral opioid agonist formulations |
| 09/23/2004 | US20040186113 Heterocyclic amines for the treatment of conditions associated with gsk-3 |
| 09/23/2004 | US20040186106 such as (S)-N-{{(1R, 2R)-2-{4-{[2-(4-Methyl-piperazin-1-yl)-benzimidazol-1-yl]methyl}-phenyl}-cyclohex-1-yl} carbonyl}-phenylglycinamide; for treatment of ischemic brain disorders |
| 09/23/2004 | US20040186101 such as 6-(3-Chlorophenyl)-4,4-dimethyl-1,4-dihydrobenzo[d][1,3]oxazin-2-one; hormone replacement therapy |
| 09/23/2004 | US20040186099 Novel heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| 09/23/2004 | US20040186098 Method for preventing and treating hearing loss using sensorineurotrophic compounds |
| 09/23/2004 | US20040186096 Drugs comprising phospholipase enzyme inhibitor; chemical synthesis; anaphylaxis, allergic inflammation, asthma, rhinitis, bronchitis, pneumonia, adult respiratory distress syndrome, inflammatory intestine disorder, Crohn's disease, ulcerative colitis, ischemia/reperfusion injuries, vasculitis |
| 09/23/2004 | US20040186090 New amidino derivatives and their use as thrombin inhibitors |
| 09/23/2004 | US20040186076 Pharmaceutical complex |
| 09/23/2004 | US20040186061 Novel derivatives of 3,3-diphenylpropylamines |
| 09/23/2004 | US20040186051 Apo-2 ligand variants and uses thereof |
| 09/23/2004 | US20040186050 Method for orally administering parathyroid hormone (pth) |